Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
Alexander GG Turpie,1 André C Schmidt,2 Reinhold Kreutz,3 Michael R Lassen,4 Waheed Jama,1,2 Lorenzo Mantovani,5 Sylvia Haas61Department of Medicine, Hamilton Health Sciences, General Division, Ontario, Canada; 2Bayer Healthcare Pharmaceuticals, Global Development, Berlin, Germany; 3I...
Main Authors: | Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-06-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/rationale-and-design-of-xamos-noninterventional-study-of-rivaroxaban-f-a10018 |
Similar Items
-
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study
by: Haas S, et al.
Published: (2016-05-01) -
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
by: Camm AJ, et al.
Published: (2014-07-01) -
Venous Thromboembolism Prophylaxis with Rivaroxaban in Elective Foot and Ankle Surgery
by: Martin J. Wiewiorski MD, et al.
Published: (2016-08-01) -
Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies
by: Sylvia Haas, et al.
Published: (2021-03-01) -
Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE
by: Walter Ageno, et al.
Published: (2017-06-01)